Alpha-Particle Based Brachytherapy Treatment of Patients with Squamous Cell Carcinoma, a New Effective Concept

The first clinical trial in humans with skin and oral cavity squamous cell carcinoma was performed in order to evaluate the effect of a unique intra-tumoral alpha radiation based tumor ablation treatment termed Diffusing Alpha emitters Radiation Therapy (DaRT). DaRT is currently the only efficient brachytherapy for treatment of the entire volume of solid tumors by alpha radiation. DaRT relies on alpha particles and thus, effective against hypoxic tumors. DaRT seeds can be produced with various intensities, sizes and shapes and enable custom designed seeds for individual patients to deliver a more effective and conformal treatment to unresectable tumors and metastatic lesions.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research